Capabilities

Illumina, Inc. and Solexa, Inc. v. Complete Genomics, Inc.; Illumina, Inc. and Illumina Cambridge Ltd. v. Complete Genomics, Inc.

Complete Genomics

Our attorneys secured a settlement agreement for long-term client Complete Genomics with Illumina, Inc. under which Illumina will dismiss with prejudice both lawsuits it had brought against Complete: Illumina, Inc. and Solexa, Inc. v. Complete Genomics, Inc., Case No. 10-cv-05542 EDL (N.D. Cal.); and Illumina, Inc. and Illumina Cambridge Ltd. v. Complete Genomics, Inc., Case No. 12-cv-01465 BEN BGS (S.D. Cal).

Complete will dismiss with prejudice all counterclaims. The parties have entered into mutual releases, and each party will bear its own litigation costs. No payment is being made by either party to the other, and no licenses are being granted by either party to the other.

This settlement follows on the heels of a March 2013 ruling for Complete Genomics by our legal team, in which our patent litigators secured a trio of decisions invalidating the asserted sequencing method claims of the ‘597 patent and finding not infringed the asserted kit claims of the ‘597 patent.

Email Disclaimer